Exponent Inc (EXPO) Stock Price & Analysis
Exponent Inc (EXPO) rose 2.43% to USD 61.44 as of July 25, 2026 at 03:04 UTC, according to Nexqual real-time market data.
EXPO last closed at USD 59.98; the session ranged USD 60.6–61.83 on volume of 437,720 shares. Market capitalization is $2.98B, with a 52-week range of USD 51.91–81.95 (NMS). Source: Nexqual, July 25, 2026 at 03:04 UTC.
Key Statistics (as of July 25, 2026 at 03:04 UTC)
| Price | USD 61.44 |
|---|---|
| Change | ▲ 2.43% (up) |
| Previous Close | USD 59.98 |
| Open | USD 60.68 |
| Day Range | USD 60.6 – 61.83 |
| 52-Week Range | USD 51.91 – 81.95 |
| Volume | 437,720 shares |
| Market Cap | $2.98B |
| Exchange | NMS |
Technical Analysis (EXPO)
Nexqual's technical model rates EXPO "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:04 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.1 (neutral) |
| vs SMA50 | Above (USD 58.98) |
| MACD | 0.56 (positive) |
Analyst Ratings (EXPO)
Wall Street analysts rate EXPO "None" based on 3 analysts, with a mean price target of USD 81.67 (range USD 75–90), per Nexqual as of July 25, 2026 at 03:04 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 81.67 |
| High Target | USD 90 |
| Low Target | USD 75 |
| Buy / Hold / Sell | 3 / 1 / 0 |
Earnings (EXPO)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0.6 |
| Revenue Estimate | $147.49M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.59 vs est 0.61 ▼ miss |
| 2025-12-31 | USD 0.49 vs est 0.47 ▲ beat |
| 2025-09-30 | USD 0.55 vs est 0.53 ▲ beat |
| 2025-06-30 | USD 0.52 vs est 0.52 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financials & Fundamentals (EXPO)
| Total Revenue | $551.14M |
|---|---|
| Revenue Growth (YoY) | +10.50% |
| Gross Margin | +35.13% |
| Operating Margin | +27.26% |
| Profit Margin | +19.76% |
| ROE | +27.94% |
| Debt / Equity | 23.95 |
| Current Ratio | 2.4 |
| Total Cash | $118.55M |
| Total Debt | $81.04M |
| Free Cash Flow | $73.84M |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Financial Health Score (EXPO)
Nexqual rates Exponent Inc's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 03:04 UTC.
| Growth | Mixed — Revenue +3.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 35%, operating 27% |
| Balance Sheet | Strong — $119M cash vs $81M debt, net cash position |
| Cash Flow | Solid — FCF $74M, 14% margin |
| Efficiency | Strong — ROE 28%, ROA 10.1% |
Ownership (EXPO)
| Insider Ownership | +1.11% |
|---|---|
| Institutional Ownership | +101.27% |
| Shares Outstanding | 48.51M |
| Float | 47.92M |
| Short % of Float | +7.85% |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
Leadership (EXPO)
Exponent Inc is led by Catherine Ford Corrigan P.E. (age 56), CEO & Director, per Nexqual as of July 25, 2026 at 03:04 UTC.
| CEO & Director | Catherine Ford Corrigan P.E. (age 56) |
|---|---|
| Executive VP, Corporate Secretary & Director | Richard L. Schlenker (age 59) |
| Group Vice President | Maureen T. F. Reitman F.S.P.E., P.E., Sc.D. (age 56) |
| Group Vice President | Joseph Rakow (age 48) |
| Group Vice President | Joseph Sala (age 48) |
Major Backers & Investors (EXPO)
Notable institutional backers of Exponent Inc include Kayne Anderson Rudnick Investment Management LLC, Conestoga Capital Advisors, LLC, Geneva Capital Management LLC, according to Nexqual as of July 25, 2026 at 03:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kayne Anderson Rudnick Investment Management LLC | 8.01% |
| Conestoga Capital Advisors, LLC | 3.93% |
| Geneva Capital Management LLC | 3.7% |
| Royce & Associates LP | 2.36% |
| Two Sigma Investments, LP | 2.27% |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 2.11% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 18.71% |
| BlackRock | 18.46% |
| State Street | 3.9% |
| Geode Capital | 3.4% |
Source: Nexqual, July 25, 2026 at 03:04 UTC.
From Exponent Inc's Latest SEC 10-K Filing (filed 2026-02-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally.
- The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
- It provides services in the areas of biomechanics, biomedical engineering and sciences, civil and structural engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, metallurgical and corrosion engineering polymer and chemistry, thermal sciences, and vehicle engineering.
- The company also offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| FELE | Franklin Electric Co., Inc. | USD 105.59 | ▲ 0.88% |
| EXLS | ExlService Holdings, Inc. | USD 27.67 | ▲ 3.13% |
| AAON | AAON, Inc. | USD 102.67 | ▼ 4.2% |
| BCPC | Balchem Corporation | USD 162.81 | ▲ 0.44% |
| CRVL | CorVel Corp. | USD 59.86 | ▲ 1.46% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:04 UTC. This page is informational and not investment advice.